Trials / Completed
CompletedNCT01114217
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 634 (actual)
- Sponsor
- AMAG Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferumoxytol | IV Ferumoxytol |
Timeline
- Start date
- 2010-07-27
- Primary completion
- 2012-09-24
- Completion
- 2013-04-23
- First posted
- 2010-05-03
- Last updated
- 2022-04-21
- Results posted
- 2018-06-11
Locations
140 sites across 6 countries: United States, Canada, Hungary, India, Latvia, Poland
Source: ClinicalTrials.gov record NCT01114217. Inclusion in this directory is not an endorsement.